A Strategic Approach to Controlling Diabetes
Adequately treating diabetes demands an array of considerations and therapy strategies.
A1C Management Strategies
Dr Handelsman drives a conversation surrounding the management of A1C levels.
Key Takeaways and Considerations Surrounding COPD Therapies
Medical experts provide their closing thoughts on the chronic obstructive pulmonary disease treatment landscape.
Cost Drivers Impacting Treatment Strategies for COPD
Cost drivers and payer considerations are emphasized for treatment of patients with chronic obstructive pulmonary disease.
Clinical Trial Eligibility and Considerations for Patients with Rett Syndrome
A key opinion leader shares considerations for seeking eligibility and enrollment in clinical trials for patients with Rett syndrome.
Unmet Needs in Treatment Landscape of Rett Syndrome
An expert highlights unmet needs in the treatment of Rett syndrome.
Role of Non-Medication Strategies in COPD Treatment Pathway
Nonmedication COPD strategies, such as pulmonary rehabilitation, are highlighted.
Individualizing Medication Therapy in Patients with COPD: Considerations with Inhalers
Selecting appropriate inhalers based on individual characteristics and shared decision-making is crucial for optimizing care for patients with COPD.
Utilizing Available Frontline Treatment in MM
Daratumumab can be an effective frontline MM treatment option.
Adequate Treatment Response in Transplant-Ineligible MM Patients
Raymond Thertulien, MD, PhD, discusses high-risk factors for patients with MM.
The Utilization of Combination Therapy in Patients with Diabetes
Key opinion leaders discuss the role of combination therapies in the management of diabetes.
Managing Blood Pressure in Patients With Diabetes
Managing hypertension is a critical aspect of diabetes disease management.
Insurance Authorization Considerations Associated With Rett Syndrome Treatment
Considerations for insurance preauthorization and reauthorization are explored by a key opinion leader.
Treatment Burden Associated with Rett Syndrome
Patients and families facing a Rett syndrome diagnosis experience an array of burdens.
Key Contributors to Long-term Outcomes for Patients With MDD
Drs Chitre and Weaver share their finals thoughts, highlighting key contributors to long-term outcomes for patients with major depressive disorder.
The Impact of Early Effective Treatment in MDD
Early effective treatment strategies can have a significant impact on long-term effects for patients with MDD.
Treatment Strategies for Hyperglycemia
The panel shares insights into the evolution of treatment strategies for patients with diabetes.
Insurance Considerations in Diabetes Management
A panel of experts discuss considerations in insurance coverage for the treatment of patients with diabetes.
Patient Frailty Impacting Multiple Myeloma (MM) Treatment Strategies
Brea C. Lipe, MD, highlights considerations for frail patients when treating for MM.
SWOG777 Trial and DRd vs VRd
Medical experts explore the SWOG-S0777 trial and present an overview of daratumumab in combination with lenalidomide and dexamethasone (DRd) vs bortezomib, lenalidomide, and low-dose dexamethasone (VRd).
Patient Education and Proper Inhaler Technique
Inhaler technique informs health care outcomes in COPD management and should be a primary focus in patient education priorities.
Optimal Management of COPD: Escalation and De-escalation of Therapy
Treatment pathways, including escalation and de-escalation of therapy, for patients with COPD are explored by a panel of medical experts.
Rett Syndrome: The Diagnostic Journey (Part 2)
Patient advocate Paige Nues elaborates on the patient journey associated with a Rett syndrome diagnosis.
Rett Syndrome: The Diagnostic Journey (Part 1)
Paige Nues, from the International Rett Syndrome Foundation, provides insights on the diagnostic journey for patients with Rett syndrome.
Aligning MDD Treatment Goals for Payers and Patients
Drs Weaver and Chitre discuss aligning key considerations for payers and goals of therapy for patients in the treatment of MDD.
Supporting Adherence for Patients with MDD
Drs Weaver and Chitre share strategies to support MDD treatment adherence across their patient populations.
Health Inequities Impacting Optimal Treatment for Patients With Psoriasis
Bruce Sherman, MD, FCCP, FACOEM, underlines the impact of health inequities for patients diagnosed with psoriasis.
The Benefits and Limitations of the PASI Score
Maria Lopes, MD, MS, provides an overview of the PASI scoring system.
The Impact of Psoriasis on the Quality of Life
Amy McMichael, MD, discusses the impact of psoriasis on a patient’s quality of life.
Prevalence and Incidence of Psoriasis
Ryan Haumschild, PharmD, MS, MBA, leads a panel discussion highlighting the current prevalence of psoriasis.
